The Relationship Between Total Lesion Activity on 18 F Choline Positron Emission Tomography-Computed Tomography and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Bone Metastases Treated with 223 Radium
Authors:
- 13 August 2020
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 35 (6) , 398-403
Abstract
The aim of the study was to assess the correlation between metabolic response measured through positron emission tomography-computed tomography (PET-CT) with 18 F choline ( 18 F FCH) and overall survival (OS) in patients affected by bone lesions from metastatic castration-resistant prostate cancer treated with 223 Ra dichloride. Eleven subjects were subjected to PET-CT with 18 F FCH before and 1 month after 223 Ra treatment. Reduction in total lesion activity (ΔTLA) between pretreatment and post-treatment scan was determined and patients were divided into responders (ΔTLA >50%) and nonresponders (ΔTLA p < 0.05). Reduction in TLA after 223 Ra treatment seems to be correlated with a trend toward a longer survival.Keywords
This publication has 7 references indexed in Scilit:
- Prognostic value of 18F–choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamideEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- Response Assessment of 223Ra TreatmentClinical Nuclear Medicine, 2017
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate CancerEuropean Urology, 2017
- Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer—Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CTDiagnostics, 2015
- Incidental Detection of Colorectal Cancer Via 18F-Choline PET/CT in a Patient With Recurrent Prostate CancerClinical Nuclear Medicine, 2015
- Changes in Skeletal Tumor Activity on 18F-choline PET/CT in Patients Receiving 223Radium Radionuclide Therapy for Metastatic Prostate CancerNuclear Medicine and Molecular Imaging, 2015
- Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?Advances in Urology, 2011